Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium

Journal of Perinatology

Volumn 26, Issue 1, 2006, Pages 11-14

  Montgomery, D ^a   Plate, C ^b   Alder, S C ^c   Jones, M ^b   Jones, J ^b   Christensen, R D ^a  

^a McKay Dee Hospital Center   (United States)

^b US Drug Testing Laboratories   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamines; Cannabinoids; Drug abuse; Meconium; Umbilical cord

Indexed keywords

AMPHETAMINE; CANNABINOID; COCAINE; ILLICIT DRUG; OPIATE; PHENCYCLIDINE;

ARTICLE; CONTROLLED STUDY; DRUG SCREENING; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; MECONIUM; MOTHER; NEWBORN; PRENATAL DRUG EXPOSURE; UMBILICAL CORD;

AMPHETAMINES; CANNABINOIDS; COCAINE; FEMALE; FETUS; HUMANS; MECONIUM; NARCOTICS; PHENCYCLIDINE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; UMBILICAL CORD;

EID: 31344434499     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211416     Document Type: Article

References (18)

1. http://www.healthypeople.gov/.
2. http://www.healthypeople.gov/document/html/objectives/16-17.htm.
3. Ostrea Jr EM, Lynn SM, Wayne RN, Stryker JC. Tissue distribution of morphine in the newborns of addicted monkeys and humans. Clinical implications. Dev Pharmacol Ther 1980; 1: 163-170.
4. Ostrea Jr EM, Brady MJ, Parks PM, Asensio DC, Naluz A. Drug screening of meconium in infants of drug-dependent mothers: An alternative to urine testing. J Pediatr 1989; 115: 474-477.
5. Ostrea Jr EM, Romero A, Yee H. Adaptation of the meconium drug test for mass screening. J Pediatr 1993; 122: 152-154.
6. Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. J Chromatogr B Biomed Sci Appl 1998; 713: 137-146.
7. Kintz P, Mangin P. Evidence of gestational heroin or nicotine exposure by analysis of fetal hair. Forensic Sci Int 1993; 63: 99-104.
8. Le NL, Reiter A, Tomlinson K, Jones J, Moore C. The detection of oxycodone in meconium specimens. J Anal Toxicol 2005; 29: 54-57.
9. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577.
10. Ostrea Jr EM, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 1992; 89: 107-113.
11. Casanova OQ, Lombardero N, Behnke M, Eyler FD, Conlon M, Bertholf RL. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine. Arch Pathol Lab Med 1994; 118: 988-993.
12. Moriya F, Chan KM, Noguchi TT, Wu PY. Testing for drugs of abuse in meconium of newborn infants. J Anal Toxicol 1994; 18: 41-45.
13. Buchi KF, Zone S, Langheinrich K, Varner MW. Changing prevalence of prenatal substance abuse in Utah. Obstet Gynecol 2003; 102: 27-30.
14. Ostrea Jr EM, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001; 138: 344-348.
15. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003; 88: F98-F100.
16. Vinner E, Vignau J, Thibault D, Codaccioni X, Brassart C, Humbert L et al. Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome. Ther Drug Monit 2003; 25: 421-432.
17. Moore C, Lewis D, Leikin J. False-positive and false-negative rates in meconium drug testing. Clin Chem 1995; 41: 1614-1616.
18. Silvestre MA, Lucena JE, Roxas Jr R, Evangelista ES, Ostrea Jr EM. Effects of timing, dosage, and duration of morphine intake during pregnancy on the amount of morphine in meconium in a rat model. Biol Neonate 1997; 72: 112-117.